Pregnancy outcome after cabergoline treatment in early weeks of gestation. - Wikidata - thesis-toulmin - TriplyDB

Pregnancy outcome after cabergoline treatment in early weeks of gestation.

Pregnancy outcome after cabergoline treatment in early weeks of gestation.

http://www.wikidata.org/entity/Q44195068

about

Managing Prolactinomas during Pregnancy Can dopamine agonists reduce the incidence and severity of OHSS in IVF/ICSI treatment cycles? A systematic review and meta-analysis Outcomes of assisted reproduction treatment after dopamine agonist -cabergoline- for prevention of ovarian hyper stimulation syndrome Parity, pregnancy and neonatal outcomes in women treated for hyperprolactinaemia compared with a control group.Management of macroprolactinomas.Anti-angiogenic treatment strategies for the therapy of endometriosis.Drug insight: Cabergoline and bromocriptine in the treatment of hyperprolactinemia in men and women.Pituitary surgery for small prolactinomas as an alternative to treatment with dopamine agonists.Diagnosis and management of hyperprolactinemia.Management of prolactinoma with cabergoline treatment in a pregnant woman during her entire pregnancy.Vanishing tumor in pregnancy.Prolactin-secreting tumors: what's new?Treatment of infertility in women with pituitary tumors.Ovarian hyperstimulation syndrome in a spontaneous pregnancy: A potential for missed-diagnosis.The use of central nervous system active drugs during pregnancy.VEGF antagonist for the prevention of ovarian hyperstimulation syndrome: Current status.Do dopamine agonists prevent or reduce the severity of ovarian hyperstimulation syndrome in women undergoing assisted reproduction? A systematic review and meta-analysis.Pituitary tumors and pregnancy: the interplay between a pathologic condition and a physiologic status.Prolactinomas, cabergoline, and pregnancy.RANZCOG CREI Consensus Statement on treatment of Ovarian Hyperstimulation Syndrome.How does pregnancy affect the patients with pituitary adenomas: a study on 113 pregnancies from Turkey.Pregnancy and tumor outcomes in infertile women with macroprolactinoma on cabergoline therapy.Pregnancy and acromegaly.Pregnancy outcome in women exposed to dopamine agonists during pregnancy: a pharmacoepidemiology study in EFEMERIS database.Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas.Cabergoline administration prevents development of moderate to severe ovarian hyperstimulation syndrome and it contributes to reduction in ovarian volume.

P2860

Q28080990-8053FC1A-46E6-412E-9CDE-396C302568BF Q28278251-8EE45EB0-B19E-4F1C-9781-99AF46E82562 Q28831447-43DBD86F-D63D-4C01-99B3-F779D4DCAF78 Q33287330-6A0EB448-2E8B-429C-B95B-34AE85B012BF Q33792371-8A697676-6681-462E-AF1A-A4BD4F009381 Q34283036-658A31F9-2120-470F-8748-3C53B6430770 Q34560466-4F8B5DF9-2FA2-4885-89E5-C27DC2EC7A08 Q35137687-837E9E52-81BF-48A1-BD53-CF7FC3BED39D Q35219497-92B584EC-1EF6-472F-8C15-2F612B1D1BD1 Q35244492-E130417C-3715-4264-BE40-DA6F60A6CB6F Q36436429-08785455-F72C-4979-B489-4AE00AF7597C Q36605350-8DFF5E49-0D4F-44A5-9A62-4912633CF2FA Q36605366-FF66CEFC-6EA3-404B-852A-664A00706479 Q36876747-AF702EA2-2A32-4F5C-AB14-24D74C738C09 Q37280003-68BBA70C-0163-4587-A522-2DFEDE137CF6 Q37624402-9C206D18-DBAF-4550-97EF-E2800CBC5188 Q38139085-E81D6B6E-336B-4286-BA83-A0E6DA9F5CD0 Q38185334-6B8AA328-BABA-48FF-A466-F35632CD65DB Q38225350-E7272DCE-585A-4E7C-843A-2C0501AF3F22 Q38568066-8F7A5EBC-D459-4D09-80C3-8E4436A8AD87 Q38716304-DD80074A-7B9C-4FC2-ABA7-B92FBC95CFA2 Q39138684-39C2D5D7-4210-458B-AF36-B4475AC10F7E Q39446485-91082953-6475-42A7-A279-5E699F278F40 Q45297173-20C87C2C-D2B6-45BA-A4A7-D5CC1D3EA6AF Q46190981-3F1F393A-6C0D-4129-A833-AFD1C52B0DAD Q47142303-32F14C99-88BF-4ABA-92BE-C4D3882DDB4C

P2860

Pregnancy outcome after cabergoline treatment in early weeks of gestation.

http://www.wikidata.org/entity/Q44195068

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

Pregnancy outcome after cabergoline treatment in early weeks of gestation.

@en

Pregnancy outcome after cabergoline treatment in early weeks of gestation.

@nl

type

label

Pregnancy outcome after cabergoline treatment in early weeks of gestation.

@en

Pregnancy outcome after cabergoline treatment in early weeks of gestation.

@nl

prefLabel

Pregnancy outcome after cabergoline treatment in early weeks of gestation.

@en

Pregnancy outcome after cabergoline treatment in early weeks of gestation.

@nl

P1433

Q44195068-A0DF4F36-3586-44B6-A540-D70D49F1CAF7

P1476

Q44195068-F3FEC018-050D-4D1F-B029-D5C5B812D7BF

P2093

Q44195068-2C3998EB-6548-42AD-8AB4-BCF5DB333407

Q44195068-5E319D62-5E6E-47CB-8739-864B48A0C87B

Q44195068-68AB9162-99B8-4115-9EAD-950D847051EE

Q44195068-6BE57B7F-3C0F-4BC2-A1A6-87159CC1F0B6

Q44195068-710DFD23-62EA-4382-9E28-904E71D06BCF

Q44195068-8FFD6B98-A379-4993-9CAF-DBE47842CAC3

Q44195068-92A8BE13-E394-42D3-AE03-16A7583E1924

Q44195068-A83AE426-7CEF-4F41-A0EC-278A969D82B1

Q44195068-A89BD189-9E96-4E20-8193-021DE50D95F5

Q44195068-C59DEAFA-B287-47D6-9E5F-DF4978DAAE80

P304

Q44195068-E8B41B3B-CD6B-4439-B3CA-45B9D51E6DE8

P31

Q44195068-482F4002-723E-4A2A-85A4-82676A73D483

P356

Q44195068-984E0931-66CF-436F-B37C-F56BE03FACBF

P433

Q44195068-01CB62FD-D716-4C13-B2C4-5D87369D5E6F

P478

Q44195068-78FB8B8A-235D-4A44-BC17-8166D60F2664

P50

Q44195068-63E9550C-BE34-46D6-8619-0F83E7FBDC07

Q44195068-6BFEEF7E-CC4E-4409-A22C-D1DB56AFE839

Q44195068-ECAD15BE-DDBF-417C-9ADD-FCF597043D18

Q44195068-F0E4E2DA-DCF2-4519-8955-E8CE266A7895

P577

Q44195068-608C2503-9B5B-4A14-B2C6-ADF05FBD9090

P698

Q44195068-11F06B7E-D399-46CD-B435-9E707D6D113B

P356

S0890-6238(02)00055-2

P1433

Reproductive Toxicology

P1476

Pregnancy outcome after cabergoline treatment in early weeks of gestation.

@en

P2093

Anna Elisa Nicolosi

http://www.w3.org/2001/XMLSchema#string

Carlo I Ferrari

http://www.w3.org/2001/XMLSchema#string

Elena Ricci

http://www.w3.org/2001/XMLSchema#string

Emanuela Gangi

http://www.w3.org/2001/XMLSchema#string

Francesca Rocchi

http://www.w3.org/2001/XMLSchema#string

Maria Luisa Landi

http://www.w3.org/2001/XMLSchema#string

Maurizio Bonati

http://www.w3.org/2001/XMLSchema#string

Maurizio Gasperi

http://www.w3.org/2001/XMLSchema#string

Maurizio Lavezzari

http://www.w3.org/2001/XMLSchema#string

Sandra Paracchi

http://www.w3.org/2001/XMLSchema#string

P304

791-793

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0890-6238(02)00055-2

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Antonio Clavenna

Fabio Parazzini

Paolo Beck-Peccoz

Annamaria Colao

P577

2002-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12401507

http://www.w3.org/2001/XMLSchema#string